SIGY · Sigyn Therapeutics, Inc. · Documents
$0.03
0.00 (-6.27%)
At close · Oct 2
Return incl. dividend (before tax)
Going-concern doubt
— flagged Nov 14, 2025
Substantial doubt about the company's ability to continue as a going concern.
“The Company had an accumulated deficit of $17,379,978 at September 30, 2025, had a working capital deficit of $3,903,920 at September 30, 2025, had net losses of $578,503 and $2,698,254, and $1,196,923 and $2,817,394 for the three and nine months ended September 30, 2025 and 2024, respectively, and net cash used in operating activities of $646,208 and $582,218 for the nine months ended September 30, 2025 and 2024, respectively, with no revenue earned since inception, and a lack of operational history. These matters raise substantial doubt about the Company's ability to continue as a going concern.”View the 10-Q filed Nov 14, 2025
Market Cap
$56,188
Shares
1.61M
Volume · Oct 2
27.05K
Avg daily vol (3M)
30.56K
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2026-02-20 | — | |
| 10-Q | 2025-11-14 | 2025-09-30 | |
| 10-Q | 2025-09-05 | 2025-06-30 | |
| 8-K | 2025-08-15 | 2025-08-14 | |
| 10-Q | 2025-05-20 | 2025-03-31 | |
| 10-K | 2025-04-15 | 2024-12-31 | |
| 8-K | 2025-03-07 | 2025-02-26 | |
| 8-K | 2025-01-16 | 2025-01-11 | |
| 8-K | 2025-01-06 | 2024-12-30 | |
| 10-Q | 2024-11-19 | 2024-09-30 | |
| 8-K | 2024-10-16 | 2024-10-07 | |
| 8-K/A | 2024-10-16 | 2024-10-04 | |
| 8-K | 2024-10-07 | 2024-10-04 | |
| 10-Q | 2024-08-19 | 2024-06-30 | |
| 8-K | 2024-06-06 | — | |
| 8-K | 2024-05-15 | — | |
| 10-Q | 2024-05-14 | 2024-03-31 | |
| 8-K | 2024-04-16 | — | |
| 10-K | 2024-02-20 | 2023-12-31 | |
| 8-K | 2024-01-31 | — | |
| 8-K | 2024-01-30 | — | |
| 8-K | 2024-01-11 | 2024-01-09 | |
| 8-K | 2024-01-08 | 2024-01-04 | |
| 8-K | 2023-12-12 | 2023-12-06 | |
| 10-Q | 2023-11-14 | 2023-09-30 | |
| 8-K | 2023-10-26 | 2023-10-20 | |
| 8-K | 2023-10-04 | — | |
| 8-K | 2023-09-19 | 2023-09-14 | |
| 10-Q | 2023-08-14 | 2023-06-30 | |
| 8-K | 2023-07-07 | 2023-06-30 | |
| 8-K | 2023-06-08 | — | |
| 10-Q | 2023-05-15 | 2023-03-31 | |
| 8-K | 2023-04-13 | 2023-04-11 | |
| 10-K | 2023-03-31 | 2022-12-31 | |
| 10-Q | 2022-11-14 | 2022-09-30 | |
| 8-K | 2022-10-05 | 2022-10-03 | |
| 10-Q | 2022-08-15 | 2022-06-30 | |
| 10-Q | 2022-05-13 | 2022-03-31 | |
| 10-K | 2022-03-21 | 2021-12-31 | |
| 8-K | 2022-03-09 | — | |
| 8-K | 2022-03-01 | 2022-02-23 | |
| 10-Q | 2021-11-12 | 2021-09-30 | |
| 8-K/A | 2021-10-26 | 2021-10-20 | |
| 8-K | 2021-10-25 | 2021-10-20 | |
| 10-Q | 2021-08-16 | 2021-06-30 | |
| 10-Q | 2021-05-17 | 2021-03-31 | |
| 8-K | 2021-05-14 | 2021-05-10 | |
| 10-K | 2021-04-06 | 2020-12-31 | |
| 8-K/A | 2020-12-30 | 2020-09-30 | |
| 10-Q | 2020-11-09 | 2020-09-30 |
Showing 1–50 of 60 filings